| 摘要 |
A process for the preparation of compounds of formula (I) <CHEM> in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, which are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders, and intermediates useful in the preparation of the compounds. |
